^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:B Acute Lymphoblastic Leukemia
    Drug:vincristine (Tubulin polymerization inhibitor)
    Drug Class:Tyrosine kinase inhibitor
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    04/04/2022
    Excerpt:
    Acute Lymphoblastic Leukemia...Regimens for Ph-positive B-ALL...TKI + vincristine + dexamethasone